Interferons News and Research

RSS
Atorvastatin could prove an effective therapy for multiple sclerosis

Atorvastatin could prove an effective therapy for multiple sclerosis

Multikine treatment increases survival in cancer patients

Multikine treatment increases survival in cancer patients

Another step forward in the battle against bacterial infections

Another step forward in the battle against bacterial infections

Advance in the fight against bacterial infections

Advance in the fight against bacterial infections

Discovery of molecular roots of asthma, arthritis, and multiple sclerosis

Discovery of molecular roots of asthma, arthritis, and multiple sclerosis

Greasing the gears that drive the interferon signal

Greasing the gears that drive the interferon signal

New Stat1 and interferon findings

New Stat1 and interferon findings

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

Combination of ribavirin and interferon is more effective in treating hepatitis C than using interferon alone

Asthmatics naturally deficient in antiviral immunity

Asthmatics naturally deficient in antiviral immunity

Study reveals how brain's immune system fights viral encephalitis

Study reveals how brain's immune system fights viral encephalitis

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

Peginterferon alfa-2b produced sustained responses in patients with chronic hepatitis B

No evidence that Glatiramer acetate slows multiple sclerosis progression

No evidence that Glatiramer acetate slows multiple sclerosis progression

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

A trial of beta-interferon-1a in inclusion-body myositis has failed to find benefit from the drug in this disease

Treatment helps 26% of black Americans with chronic hepatitis C

Treatment helps 26% of black Americans with chronic hepatitis C

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.